Commissioning a clinical proton pencil beam scanning beamline for pre-clinical ultra-high dose rate irradiations on a cyclotron-based system.

Saved in:
Bibliographic Details
Title: Commissioning a clinical proton pencil beam scanning beamline for pre-clinical ultra-high dose rate irradiations on a cyclotron-based system.
Authors: Saini J; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Erickson DPJ; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States., Vander Stappen F; Proton Therapy - Research and Development, Ion Beam Applications, Louvain-La-Neuve, Belgium., Ruth M; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Cui S; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Gorman V; Proton Therapy - Research and Development, Ion Beam Applications, Louvain-La-Neuve, Belgium., Rossomme S; Proton Therapy - Research and Development, Ion Beam Applications, Louvain-La-Neuve, Belgium., Cao N; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Ford EC; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Meyer J; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Bloch C; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Wong T; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Grassberger C; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States., Rengan R; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Zeng J; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Schwarz M; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, United States.; Radiation Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Source: Frontiers in oncology [Front Oncol] 2024 Nov 29; Vol. 14, pp. 1460288. Date of Electronic Publication: 2024 Nov 29 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1460288